跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 55 条关于
“Persanta”
全部
55
临床试验
36
药物
4
机构
3
资讯
12
去年
Persanta Advances Towards IPO with Dominari Securities to Commercialize Early Cancer Detection Technology
去年
Mersana Therapeutics Stock Drops Following Phase 1 Trial Data Release
2年前
THINK Surgical's TMINI Robot Cleared for Zimmer Biomet's Persona Knee System
10个月前
Day One Biopharmaceuticals Acquires Mersana Therapeutics for $129M, Targeting Rare Cancer Treatment
去年
Mersana Therapeutics Receives Buy Rating Based on Promising Clinical Data and Strong Financials
10个月前
Day One Biopharmaceuticals Acquires Mersana Therapeutics for $25 Per Share in $285 Million Deal
8个月前
Day One Biopharmaceuticals Reports Strong OJEMDA Revenue Growth and Expands Pipeline Through Mersana Acquisition
去年
Emiltatug Ledadotin (XMT-1660) Shows Promise in Phase 1 Trial, Receives FDA Fast Track for Advanced Breast Cancer
9个月前
Versant Ventures Launches Dayra Therapeutics with $70M Funding and Biogen Partnership for Oral Macrocyclic Peptides
10个月前
Day One Biopharmaceuticals Acquires Mersana Therapeutics for $285 Million to Advance Novel ADC for Rare Cancer
第 1 页,共 2 页
上一页
下一页